US-based compact proton therapy technology company ProTom International on Friday unveiled its new Radiance 330-C Proton Therapy System, a compact and modular proton therapy solution.
The fixed-beam system allows healthcare providers to add single or multiple treatment rooms within existing Linac vaults in radiation oncology departments, reducing overall costs.
Integrated with Leo Cancer Care's upright patient positioning and imaging system, the Radiance 330-C offers gantry-less proton therapy without compromising treatment quality.
It features Fidelity pencil beam scanning technology, enabling precise dose delivery and real-time adaptive therapy.
The system's stationary beam delivery enhances reliability and reduces maintenance, while its compact synchrotron accelerator supports a treatment energy range of 70 MeV to 250 MeV.
ProTom added that the system is not yet available for clinical use.
Imugene announces Azer-cel Phase 1b clinical trial data
CARsgen successfully defends European GPC3 CAR-T patent
IGI and AbbVie enter global licensing agreement for ISB 2001
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Zhimeng Biopharma's CB03-154 ALS Phase 2/3 study receives Chinese clinical trial approval
Taiho Oncology and Taiho Pharmaceutical's INQOVI/venetoclax combination sNDA accepted by US FDA
SciBase introduces Nevisense pilot at Florida research university
Exact Sciences secures Medicare coverage for Oncodetect MRD test in colorectal cancer
Tyra Biosciences to announce TYRA-300 preclinical results at ENDO 2025
Centivax raises USD45m to commercialise universal flu vaccine
Adcentrx Therapeutics' ADRX-0405 granted US FDA orphan drug designation
Avenzo Therapeutics doses first patient in AVZO-1418/DB-1418 Phase 1/2 clinical study